Lingua: Inglese
Editore: Royal Society of Chemistry, 2018
ISBN 10: 1788010833 ISBN 13: 9781788010832
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 194,65
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: New. NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Lingua: Inglese
Editore: Royal Society of Chemistry, 2018
ISBN 10: 1788010833 ISBN 13: 9781788010832
Da: Ria Christie Collections, Uxbridge, Regno Unito
EUR 241,10
Quantità: 16 disponibili
Aggiungi al carrelloCondizione: New. In.
Lingua: Inglese
Editore: Royal Society of Chemistry, GB, 2018
ISBN 10: 1788010833 ISBN 13: 9781788010832
Da: Rarewaves.com USA, London, LONDO, Regno Unito
EUR 264,82
Quantità: 4 disponibili
Aggiungi al carrelloHardback. Condizione: New. Kinase inhibition remains an area of significant interest, and growing importance, across academia and the pharmaceutical industry. There are now many marketed drugs that target kinases and a significant number of compounds are currently in various stages of clinical development. This book is a forward-looking analysis of a number of key areas for kinase inhibition in the coming years and builds on the first volume. This includes topics such as screening approaches to target kinases along with different modes of inhibition such as allosteric and covalent. Novel approaches such as macrocyclisation are considered along with how the properties of kinase inhibitors have evolved, including the potential for brain penetration. Recent areas of great importance also covered include cutting edge molecular modelling approaches and the importance of kinase mutations. The evolving biology of kinases has also resulted in increased interest in the immuno-oncology area and also pseudokinases as a target family. As with the first volume the book finishes with a forward looking view of how research against this fascinating target class may evolve.
Lingua: Inglese
Editore: Royal Society of Chemistry, Cambridge, 2018
ISBN 10: 1788010833 ISBN 13: 9781788010832
Da: Grand Eagle Retail, Bensenville, IL, U.S.A.
Hardcover. Condizione: new. Hardcover. Kinase inhibition remains an area of significant interest, and growing importance, across academia and the pharmaceutical industry. There are now many marketed drugs that target kinases and a significant number of compounds are currently in various stages of clinical development. This book is a forward-looking analysis of a number of key areas for kinase inhibition in the coming years and builds on the first volume. This includes topics such as screening approaches to target kinases along with different modes of inhibition such as allosteric and covalent. Novel approaches such as macrocyclisation are considered along with how the properties of kinase inhibitors have evolved, including the potential for brain penetration. Recent areas of great importance also covered include cutting edge molecular modelling approaches and the importance of kinase mutations. The evolving biology of kinases has also resulted in increased interest in the immuno-oncology area and also pseudokinases as a target family. As with the first volume the book finishes with a forward looking view of how research against this fascinating target class may evolve. This book is a forward-looking analysis of a number of key areas for kinase inhibition in the coming years. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.
Lingua: Inglese
Editore: ROYAL SOCIETY OF CHEMISTRY, 2018
ISBN 10: 1788010833 ISBN 13: 9781788010832
Da: moluna, Greven, Germania
EUR 232,43
Quantità: 5 disponibili
Aggiungi al carrelloCondizione: New. This book is a forward-looking analysis of a number of key areas for kinase inhibition in the coming years.Über den AutorrnrnDr Frederick W Goldberg is a Medicinal Chemist at AstraZeneca, UK. He received his MSci at Cambridge University.
Lingua: Inglese
Editore: Royal Society of Chemistry, GB, 2018
ISBN 10: 1788010833 ISBN 13: 9781788010832
Da: Rarewaves.com UK, London, Regno Unito
EUR 250,49
Quantità: 4 disponibili
Aggiungi al carrelloHardback. Condizione: New. Kinase inhibition remains an area of significant interest, and growing importance, across academia and the pharmaceutical industry. There are now many marketed drugs that target kinases and a significant number of compounds are currently in various stages of clinical development. This book is a forward-looking analysis of a number of key areas for kinase inhibition in the coming years and builds on the first volume. This includes topics such as screening approaches to target kinases along with different modes of inhibition such as allosteric and covalent. Novel approaches such as macrocyclisation are considered along with how the properties of kinase inhibitors have evolved, including the potential for brain penetration. Recent areas of great importance also covered include cutting edge molecular modelling approaches and the importance of kinase mutations. The evolving biology of kinases has also resulted in increased interest in the immuno-oncology area and also pseudokinases as a target family. As with the first volume the book finishes with a forward looking view of how research against this fascinating target class may evolve.
Lingua: Inglese
Editore: Royal Society Of Chemistry Nov 2018, 2018
ISBN 10: 1788010833 ISBN 13: 9781788010832
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 286,26
Quantità: 2 disponibili
Aggiungi al carrelloBuch. Condizione: Neu. Neuware - Kinase inhibition remains an area of significant interest, and growing importance, across academia and the pharmaceutical industry. There are now many marketed drugs that target kinases and a significant number of compounds are currently in various stages of clinical development. This book is a forward-looking analysis of a number of key areas for kinase inhibition in the coming years and builds on the first volume. This includes topics such as screening approaches to target kinases along with different modes of inhibition such as allosteric and covalent. Novel approaches such as macrocyclisation are considered along with how the properties of kinase inhibitors have evolved, including the potential for brain penetration. Recent areas of great importance also covered include cutting edge molecular modelling approaches and the importance of kinase mutations. The evolving biology of kinases has also resulted in increased interest in the immuno-oncology area and also pseudokinases as a target family. As with the first volume the book finishes with a forward looking view of how research against this fascinating target class may evolve.
Lingua: Inglese
Editore: Royal Society of Chemistry, Cambridge, 2018
ISBN 10: 1788010833 ISBN 13: 9781788010832
Da: AussieBookSeller, Truganina, VIC, Australia
EUR 400,28
Quantità: 1 disponibili
Aggiungi al carrelloHardcover. Condizione: new. Hardcover. Kinase inhibition remains an area of significant interest, and growing importance, across academia and the pharmaceutical industry. There are now many marketed drugs that target kinases and a significant number of compounds are currently in various stages of clinical development. This book is a forward-looking analysis of a number of key areas for kinase inhibition in the coming years and builds on the first volume. This includes topics such as screening approaches to target kinases along with different modes of inhibition such as allosteric and covalent. Novel approaches such as macrocyclisation are considered along with how the properties of kinase inhibitors have evolved, including the potential for brain penetration. Recent areas of great importance also covered include cutting edge molecular modelling approaches and the importance of kinase mutations. The evolving biology of kinases has also resulted in increased interest in the immuno-oncology area and also pseudokinases as a target family. As with the first volume the book finishes with a forward looking view of how research against this fascinating target class may evolve. This book is a forward-looking analysis of a number of key areas for kinase inhibition in the coming years. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.